Copyright
©The Author(s) 2020.
World J Stem Cells. Sep 26, 2020; 12(9): 922-937
Published online Sep 26, 2020. doi: 10.4252/wjsc.v12.i9.922
Published online Sep 26, 2020. doi: 10.4252/wjsc.v12.i9.922
Priming factor | MSCs source | Immunomodulatory effects of inflammatory priming | Suggested mechanism | Ref. | |
Pro-inflammatory cytokines | IFN-γ | hWJ-MSCs | ↓ Th1 and Th17 cells proliferation | ↑ CXCL9, CXCL10, CXCL11, ICAM-1, VCAM-1, IDO1 and HLA-G5 gene expression | Wang et al[35], 2016 |
↑ Th2 and Tregs (CD4+, CD25+, CD127dim/− cells) percentage | ↓ IFNγ, TNFα but ↑ IL-10 and IL-6 secretion in co-culture with PB-MNCs | ||||
hBM-MSCs | ↓ T-cell effector functions and Th1 cytokine (IFN-γ, TNF-α, and IL-2) production | ↑ B7H1 and B7DC (ligands for PD1) expression | Chinnadurai et al[36], 2014 | ||
IFN-γ and TNF-α | hBM-MSCs | ↓ T cell proliferation | ↑ IDO activity | François et al[55], 2012 | |
↑ Monocyte differentiation into M2 (IL-10-secreting CD206+) immunosuppressive macrophages | |||||
↓ CD3/CD28-induced T-cell proliferation | ↓ Potency to trigger increased IFN-γ and IL-2 synthesis by activated T cells | Cuerquis et al[59], 2014 | |||
TNF-α/IFN-γ and IL-β | rBM-MSCs | ↓ Proliferation of syngeneic lymphocytes | ↑ NO production | Murphy et al[80], 2019 | |
IL-17 | hBM-MSCs | ↓ PHA-stimulated T-cell proliferation | ↑ IL-6 gene expression | Sivanathan et al[94], 2015 | |
↓ Expression of CD25 on CD4+ effector T cells | Treg-mediated IL-2 deprivation | ||||
↓ T cell effector function and Th1 cytokines (IFN-γ, TNF-α, IL-2) secretion | |||||
↑ Formation of Tregs (CD4+ CD25 high CD127 low FoxP3+) | Cell-contacts and ↑ PGE2 and TGF-β expression | ||||
IFN-γ, TNF-α and IL-17 | mBM-MSC | ↓ T-cell proliferation | ↑ iNOS expression | Han et al [95], 2014 | |
IFN-γ, TNF-α and IL-6 | hAT-MSC | ↓ Proliferation of PHA or MLR activated PB-MNCs | ↑ IDO expression | Crop et al[111], 2010 | |
Alarmins | IL-1α | hBM-MSCs | ↓ IL-6, TNF-α and ↑ IL-10 secretion in LPS-activated mouse microglial BV2 cells | ↑ G-CSF secretion | Redondo-Castro et al[78], 2017 |
HMGB1 | hBM-MSC | Unaffected inhibition of Con A-induced lymphocyte proliferation | / | Meng et al[118], 2008 |
- Citation: Jauković A, Kukolj T, Obradović H, Okić-Đorđević I, Mojsilović S, Bugarski D. Inflammatory niche: Mesenchymal stromal cell priming by soluble mediators. World J Stem Cells 2020; 12(9): 922-937
- URL: https://www.wjgnet.com/1948-0210/full/v12/i9/922.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i9.922